Telehealth for Pediatric Care

Telehealth delivery of pediatric services has expanded significantly across all 50 states, reshaping how children receive acute, developmental, and chronic condition management outside traditional clinical settings. This page covers the definition and regulatory scope of pediatric telehealth, the technical and clinical mechanisms through which it operates, the conditions most commonly addressed remotely, and the clinical and legal boundaries that govern when in-person care is required. Pediatric telehealth carries distinct considerations related to consent, guardian participation, developmental assessment, and state licensure that distinguish it from adult-focused virtual care.

Definition and scope

Pediatric telehealth refers to the use of electronic communications and information technology to deliver health-related services and information to patients under 18 years of age. The American Academy of Pediatrics (AAP) defines telehealth broadly to include synchronous video visits, asynchronous store-and-forward consultations, and remote patient monitoring — all adapted to the developmental and legal status of the pediatric patient.

The regulatory framework governing pediatric telehealth draws from multiple federal and state sources. The Centers for Medicare & Medicaid Services (CMS) establishes coverage criteria under Medicaid, which covers approximately 41 million children in the United States (CMS, Medicaid & CHIP enrollment data). The Children's Health Insurance Program (CHIP) extends telehealth-eligible coverage to children in households above Medicaid income thresholds. Individual state Medicaid programs set their own telehealth coverage rules, making state-level policy variation a primary driver of access disparities.

Under the Health Insurance Portability and Accountability Act (HIPAA), pediatric patients are afforded the same privacy protections as adults, but the Privacy Rule at 45 CFR § 164.502(g) generally grants parents and legal guardians rights as personal representatives over a minor's health information. State minor consent laws may carve out exceptions for specific sensitive services such as mental health, substance use, and reproductive health — areas where adolescents may consent independently.

Licensure requirements demand that the treating clinician hold an active license in the state where the pediatric patient is physically located at the time of the visit, consistent with the interstate licensure framework and the standards of the Federation of State Medical Boards (FSMB).

How it works

Pediatric telehealth visits operate through one of two primary modalities — synchronous or asynchronous — each suited to different clinical contexts. A detailed comparison appears in the synchronous vs. asynchronous telehealth reference page.

Synchronous (real-time) video visits constitute the dominant model for pediatric telehealth. The encounter requires:

1. Scheduling and consent collection — A parent or legal guardian provides informed consent, consistent with state-specific requirements under telehealth informed consent standards. For adolescents of sufficient age and maturity, assent documentation is considered best practice by the AAP.
2. Identity and eligibility verification — The platform confirms patient identity, insurance eligibility, and clinician licensure relative to the patient's state of residence.
3. Technical environment setup — Audio and video connections must meet minimum quality thresholds. The Federal Communications Commission (FCC) identifies 25 Mbps download / 3 Mbps upload as the benchmark for healthcare video conferencing (FCC Broadband Speed Guide).
4. Clinical encounter — A parent or caregiver participates actively. The clinician observes the child via video, collects a history from the caregiver, and may guide a structured parent-assisted physical exam using described inspection and palpation techniques.
5. Documentation and follow-up — The visit is recorded in an electronic health record, and care instructions, prescriptions, or referrals are issued per applicable law.

Asynchronous (store-and-forward) models are used in pediatric dermatology, school-based telehealth programs, and specialist consultation. Images, symptom questionnaires, and recorded observations are submitted by caregivers and reviewed by clinicians outside real-time interaction.

School-based telehealth programs represent a distinct delivery channel. Under these arrangements, school nurses or health aides serve as clinical presenters, facilitating the child's encounter with a remote provider from within the school building — a model supported by the Health Resources & Services Administration (HRSA) under the School-Based Telehealth program (HRSA Telehealth Programs).

Common scenarios

Pediatric telehealth is most clinically appropriate for conditions and circumstances that do not require hands-on physical examination or emergency intervention. The following categories represent the most documented use cases in research-based literature and CMS coding guidance:

• Acute minor illness — Upper respiratory infections, ear complaints (for follow-up after prior examination), urinary tract infection symptom assessment, rash identification in established patients, and conjunctivitis
• Behavioral and developmental services — Autism spectrum disorder (ASD) therapy sessions, ADHD medication management, developmental milestone screenings, and applied behavior analysis (ABA) parent coaching
• Mental health — Anxiety, depression, and adjustment disorder follow-up; crisis triage (not crisis intervention); telepsychiatry consultation for psychopharmacology
• Chronic disease management — Asthma action plan review, type 1 and type 2 diabetes monitoring (see telehealth diabetes management), and eczema follow-up
• Preventive and anticipatory guidance — Well-child visit components related to nutrition, sleep, screen time, and developmental milestones, recognized by the AAP as telehealth-deliverable for established patients

The AAP's 2021 policy statement on telehealth explicitly endorses synchronous visits for behavioral health, care coordination, and chronic illness management while identifying limitations for newborn assessments and first-time acute care visits where physical examination is diagnostically essential.

Decision boundaries

Determining whether a pediatric encounter is appropriate for telehealth requires assessment across four axes: clinical complexity, age and developmental stage, caregiver capacity, and legal consent status.

Telehealth-appropriate indicators:
- Established patient relationship with a documented prior physical examination
- Condition category is behavioral, psychiatric, chronic, or involves follow-up of a previously examined problem
- A parent or competent caregiver is present and able to participate in a guided assessment
- No objective finding requiring hands-on examination (e.g., auscultation for cardiac murmur, palpation for abdominal tenderness) is anticipated as diagnostic

Telehealth-contraindicated indicators (in-person required):
- Acute respiratory distress, suspected fracture, febrile infant under 3 months of age, or any scenario meeting criteria for emergency medical assessment under EMTALA (42 CFR § 489.24)
- New patient encounter for a condition where physical examination findings would materially change diagnosis or treatment
- Developmental assessments requiring standardized in-person tools (e.g., Bayley Scales, formal hearing screening)
- Conditions requiring specimen collection, imaging, or procedures

Consent and guardian complexity — When a minor patient's legal custody is divided between parents or involves state guardianship, clinicians and platforms must verify consent authority before initiating a visit. State minor consent exceptions — covering 12 categories in some states including California — require that platforms and clinicians consult applicable state statutes before restricting or granting adolescent self-consent.

Prescribing boundaries — Federal and state telehealth prescribing laws govern what medications may be prescribed following a telehealth-only encounter. For pediatric ADHD, stimulant medications classified under Schedule II of the Controlled Substances Act are subject to DEA regulations reviewed at DEA telemedicine prescribing regulations. The Controlled Substances Act definitions were amended effective December 23, 2024, to correct a technical error in the statutory definitions; clinicians and platforms should consult the current amended statutory text when evaluating scheduling classifications, as the correction may affect how specific substances are categorized or defined. Special registration requirements continue to apply and should be evaluated against the current amended text.

Technology and access barriers — Low-bandwidth environments and caregiver digital literacy gaps create clinical risk. HRSA's Rural Health Policy identifies broadband access as a structural barrier affecting pediatric telehealth in rural areas (HRSA Rural Health). When connectivity cannot sustain a video encounter meeting minimum quality standards, telephone-only visits require separate documentation of clinical appropriateness and may have distinct reimbursement status under CMS.

References

• American Academy of Pediatrics (AAP) — Telehealth Policy
• Centers for Medicare & Medicaid Services (CMS) — Medicaid & CHIP Enrollment Data
• Health Resources & Services Administration (HRSA) — Telehealth Programs
• Federal Communications Commission (FCC) — Broadband Speed Guide
• Federation of State Medical Boards (FSMB) — Telemedicine Policies
• U.S. Department of Health and Human Services — HIPAA Privacy Rule, 45 CFR § 164.502(g)